I agree. You really have to decide what your goal is when you choose a peptide, and then how you're going to monitor the outcome. Dosing varies among individuals when you start measuring outcomes. Create a plan and then stick with it for a while. By the way, none of the weight loss-oriented peptides are going to provide you with any long-term, durable results, unless you also modify your eating behavior.
@jackiadler84@overton_news By inference, the implication is he's upset because Trump won the last election and is the president at large. Get over it. He made a good point.
@DailySignal this is so silly if you want to partner with somebody you should choose the partner that has the most technological advantage. thank goodness for israeli ingenuity he's a fool
First of all, not all API comes from China. The majority of it does, but pharmacies that are 503A or 503B have to source their peptides from manufacturers, even in China, that meet certain FDA regulations. I purchased from a pharmacy that sources 80% of its API in Japan. The remainder from a 503A facility in Hong Kong. FYI.
@RyanJeffcoat28@friedberg@RoKhanna@elonmusk@JoeBiden How about creating 160,000 jobs that the taxpayers do not fund? How about launching 80% of all scientific and technology satellites into space? How about rescuing astronauts stranded in the International Space Station for a year? Tell us exactly what you have done, Ryan.
What’s hard for me to understand is how anyone can justify murder because you were pushed? It seems like a very primitive view of societal organization. Similar to honor killings, sharia law and the laws of nature where death is an accepted consequence of being in the wrong place. I wonder how we get past this mentality as a nation. I do feel bad for this fellow because I know he will have a hard and disappointing life and likely die prematurely.
If you were wondering what the "pause" was all about, Ben Thompson @stratechery has an interesting theory:
"Late last week the Anthropic Institute released a new safety report warning about the danger of recursive self-improvement... I don’t think the timing is a coincidence. This is a company and leadership that has been honing safety-and-scaremongering-as-marketing-tactic ever since Amodei led the charge to close source OpenAI models because GPT-2 was too dangerous; it’s always fun to see the evolution of tactics, capabilities, and goals, and in this case publishing a widely-discussed report the week before you cite it to silently degrade your offering for potential competitors is impressive."